Search Results 611-620 of 21315 for anti-TNF drugs

1. Sevoflurane (Inhalation Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Cabotegravir And Rilpivirine (Intramuscular Route) Description and Brand Names - Mayo Clinic

   HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients to replace their current anti-HIV medicines ...

3. Simvastatin And Niacin (Oral Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

4. Statins for the Treatment of NASH - Mayo Clinic

   Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

5. Tobramycin And Dexamethasone (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Tobradex; Tobradex ST. Canadian Brand Name.

6. Umeclidinium And Vilanterol (Inhalation Route) Description and Brand Names - Mayo Clinic

   Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the ...

7. Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death - Mayo Clinic News Network

   Also, antifungal medications are expensive and can interact with other medications. Therefore, the health care team must monitor anti-fungal medications closely ...

8. Mayo Clinic researchers present findings at the 2019 San Antonio Breast Cancer Symposium

   ... Anti-inflammatory Drugs". Embargoed until Friday, Dec. 13, at 6 p.m. EST. Research from Mayo Clinic investigators suggest that some women with an elevated ...

9. New treatment option for early type 1 diabetes - Mayo Clinic

   According to findings published in The New England Journal of Medicine in 2023, teplizumab is an anti-CD3 antibody approved for people 8 years and older ...

10. Antithymocyte Globulin Rabbit (Intravenous Route) Precautions - Mayo Clinic

    While you are being treated with anti-thymocyte globulin (rabbit), and after you stop treatment with it, it is important to see your doctor about the ...